News
New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...
People with Parkinson’s often stay silent about their diagnosis. Here’s what drives that silence and why understanding it ...
The company completed a clinical trial at nine centers across the U.S., Europe and Asia before it received FDA approval.
Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...
The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results